Table II. Parameter evaluation affecting overall survival (OS) of patients treated with pembrolizumab (n=75).
PS: Performance status; HB: hemoglobin; TFPC: time from prior chemotherapy; CI: confidence interval. *Statistically significant.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.